# Liver Metabolism at the Crossroads: The Reciprocal Control of Nutrient-Sensing Nuclear Receptors and Autophagy

**Authors:** Eun Young Kim, Jae Man Lee

PMC · DOI: 10.3390/ijms26125825 · International Journal of Molecular Sciences · 2025-06-18

## TL;DR

This paper reviews how two liver receptors, PPARα and FXR, control metabolism and autophagy, and how these processes interact to affect liver health.

## Contribution

The paper highlights the reciprocal relationship between autophagy and nutrient-sensing nuclear receptors in liver metabolism.

## Key findings

- PPARα promotes autophagy while FXR inhibits it, affecting liver metabolism.
- Disruption of autophagy impairs the function of PPARα and FXR in metabolic regulation.
- The interplay between these receptors and autophagy offers potential for treating liver disorders.

## Abstract

Peroxisome proliferator-activated receptor α (PPARα, encoded by NR1C1) and farnesoid X receptor (FXR, encoded by NR1H4) are the two prominent nutrient-sensing nuclear receptors essential for maintaining hepatic metabolism during fasting and fed states, respectively. These nuclear receptors comprehensively regulate the transcription of numerous genes involved in fatty acid oxidation (FAO), ketogenesis, bile acid (BA) biosynthesis, and other metabolic processes critical for liver energy homeostasis. These receptors have been shown to have opposite impacts on autophagy, which is triggered by PPARα activation but inhibited by FXR activation. Recent studies have further revealed that liver-specific genetic ablation of key autophagic genes tremendously impairs the activation of these nuclear receptors, thereby profoundly affecting hepatic metabolism in both fasting and feeding states. This review explores the roles and mechanisms of PPARα and FXR in regulating liver metabolism and autophagy, highlighting the necessity of basal autophagic activity in ensuring the proper signaling of these nutrient-sensing nuclear receptors. Finally, we examine the potential therapeutic strategies that leverage the interplay between PPARα, FXR, and autophagy for the treatment of metabolic liver disorders. We also delve into the clinical implications of this complex relationship, emphasizing its significance for translational medicine and future therapeutic interventions.

## Linked entities

- **Genes:** PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465], NR1H4 (nuclear receptor subfamily 1 group H member 4) [NCBI Gene 9971]
- **Proteins:** PPARA (peroxisome proliferator activated receptor alpha), NR1H4 (nuclear receptor subfamily 1 group H member 4)

## Full-text entities

- **Genes:** NR1H4 (nuclear receptor subfamily 1 group H member 4) [NCBI Gene 9971] {aka BAR, FXR, HRR-1, HRR1, PFIC5, RIP14}, PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}
- **Diseases:** metabolic liver disorders (MESH:D017093)
- **Chemicals:** BA (MESH:D001647), fatty acid (MESH:D005227)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12192644/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12192644/full.md

## References

247 references — full list in the complete paper: https://tomesphere.com/paper/PMC12192644/full.md

---
Source: https://tomesphere.com/paper/PMC12192644